Moleculin Biotech logo

Moleculin Biotech share price today

(MBRX)

Moleculin Biotech share price is $1.79 & ₹153.60 as on 7 Jan 2025, 2.30 'hrs' IST

$1.79

Market is closed - opens 8 PM, 07 Jan 2025

View live Moleculin Biotech share price in Dollar and Rupees. Guide to invest in Moleculin Biotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Moleculin Biotech, along with analyst recommendations, forecasts, and comprehensive financials.

Moleculin Biotech share price movements

  • Today's Low: $1.71
    Today's High: $1.90

    Day's Volatility :10.0%

  • 52 Weeks Low: $1.50
    52 Weeks High: $13.50

    52 Weeks Volatility :88.89%

Moleculin Biotech Returns

PeriodMoleculin Biotech, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-28.4%
-8.4%
0.0%
6 Months
-44.96%
-3.8%
0.0%
1 Year
-83.4%
-0.1%
0.0%
3 Years
-93.26%
2.9%
-19.8%

Moleculin Biotech Key Statistics

in dollars & INR

Previous Close
$1.79
Open
$1.79
Today's High
$1.8999
Today's Low
$1.71
Market Capitalization
$5.4M
Today's Volume
$43.9K
52 Week High
$13.5
52 Week Low
$1.5
Revenue TTM
$0.0
EBITDA
$-28.8M
Earnings Per Share (EPS)
$-12.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-141.49%

How to invest in Moleculin Biotech from India?

It is very easy for Indian residents to invest directly in Moleculin Biotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Moleculin Biotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Moleculin Biotech or MBRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Moleculin Biotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Moleculin Biotech shares which would translate to 0.479 fractional shares of Moleculin Biotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Moleculin Biotech, in just a few clicks!

Returns in Moleculin Biotech for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Moleculin Biotech investment value today

Current value as on today

₹19,812

Returns

₹80,188

(-80.19%)

Returns from Moleculin Biotech Stock

₹83,411 (-83.41%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Moleculin Biotech

38%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Moleculin Biotech on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 38% more investors are searching Moleculin Biotech in the last 30 days versus the previous period.

Global Institutional Holdings in Moleculin Biotech

  • Armistice Capital, LLC

    9.66%

  • Vanguard Group Inc

    2.38%

  • LPL Financial Corp

    1.20%

  • Geode Capital Management, LLC

    0.73%

  • BlackRock Inc

    0.42%

  • Renaissance Technologies Corp

    0.37%

Analyst Recommendation on Moleculin Biotech

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Moleculin Biotech(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Moleculin Biotech

What analysts predicted

Upside of 905.59%

Current:

$1.79

Target:

$18.00

Insights on Moleculin Biotech

  • Price Movement

    In the last 1 month, MBRX stock has moved down by -31.9%
  • MBRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 109.5%
  • MBRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 148.5%

Moleculin Biotech Technicals Summary

Sell

Neutral

Buy

Moleculin Biotech is currently in a neutral trading position according to technical analysis indicators.

Moleculin Biotech Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Moleculin Biotech, Inc.
-30.62%
-44.96%
-83.4%
-93.26%
-97.91%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Moleculin Biotech, Inc.
NA
NA
0.0
-14.09
-1.41
-0.57
NA
3.36
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Moleculin Biotech, Inc.
Buy
$5.4M
-97.91%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Moleculin Biotech

moleculin biotech, inc. is a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at m.d. anderson cancer center. our lead product candidate is annamycin, a phase ii clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as aml. we also have two pre-clinical small molecule portfolios, one of which is focused on the modulation of hard-to-target tumor cell signaling mechanisms and the recruitment of the patient’s own immune system. the other portfolio targets the metabolism of tumors.
Organization
Moleculin Biotech
Employees
18
CEO
Mr. Walter V. Klemp
Industry
Health Technology

Management People of Moleculin Biotech

NameTitle
Mr. Walter V. Klemp
Co-Founder, Chairman, President & CEO
Mr. Jonathan P. Foster CPA
Executive VP & CFO
Dr. Donald H. Picker Ph.D.
Chief Scientific Officer
Dr. Waldemar Priebe Ph.D.
Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board
Dr. John Paul Waymack M.D., Sc.D.
Senior Chief Medical Officer
Dr. Sandra L. Silberman M.D., Ph.D.
Chief Medical Officer of New Products
Dr. Wolfram C. M. Dempke M.B.A., M.D., Ph.D.
European Chief Medical Officer

Important FAQs about investing in Moleculin Biotech from India :

What is Moleculin Biotech share price today?

Moleculin Biotech share price today stands at $1.79, Open: $1.79 ; Previous Close: $1.79 ; High: $1.90 ; Low: $1.71 ; 52 Week High: $13.50 ; 52 Week Low: $1.50. The stock opens at $1.79, after a previous close of $1.79. The stock reached a daily high of $1.90 and a low of $1.71, with a 52-week high of $13.50 and a 52-week low of $1.50.

Can Indians buy Moleculin Biotech shares?

Yes, Indians can invest in the Moleculin Biotech (MBRX) from India.

With INDmoney, you can buy Moleculin Biotech at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Moleculin Biotech at zero transaction cost.

How can I buy Moleculin Biotech shares from India?

It is very easy to buy Moleculin Biotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Moleculin Biotech be purchased?

Yes, you can buy fractional shares of Moleculin Biotech with INDmoney app.

What are the documents required to start investing in Moleculin Biotech stocks?

To start investing in Moleculin Biotech, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Moleculin Biotech

Today’s highest price of Moleculin Biotech (MBRX) is $1.90.

Today’s lowest price of Moleculin Biotech (MBRX) is $1.71.

What is today's market capitalisation of Moleculin Biotech

Today's market capitalisation of Moleculin Biotech MBRX is 5.4M

What is the 52 Week High and Low Range of Moleculin Biotech

  • 52 Week High

    $13.50

  • 52 Week Low

    $1.50

What are the historical returns of Moleculin Biotech?

  • 1 Month Returns

    -30.62%

  • 3 Months Returns

    -44.96%

  • 1 Year Returns

    -83.4%

  • 5 Years Returns

    -97.91%

Who is the Chief Executive Officer (CEO) of Moleculin Biotech

Mr. Walter V. Klemp is the current Chief Executive Officer (CEO) of Moleculin Biotech.